VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AEHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AEHRAehr Test Systems
$53.57$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAEHRCash Flow

Aehr Test Systems (AEHR) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow margin ranged from -46.0% to +16.6% over the window and operating cash flow was -$3.1M in 2027Q1 despite $7.2M of net income, suggesting cash conversion remains unstable and dependent on working capital swings of up to -$12.7M in a single quarter.

Income StatementBalance SheetCash FlowRatios

AEHR Cash Flow Statement

Annual statement

AEHR Cash Flow Statement

Aehr Test Systems (AEHR) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMMay'26May'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Cash from Operations-6.08M-3.31M-7.4M1.76M10.01M1.51M-2.7M-2.02M-5.64M-1.35M-4.5M-6.28M-2.26M-607K-310K-4.88M-4.14M3.25M-11.04M3.62M-1.11M1.5M-2.54M-800K-3.81M-226K1.01M-5.96M342K-664K3M
Operating CF Margin %--6.62%-12.55%2.65%15.41%2.97%-16.27%-9.08%-26.77%-4.57%-23.79%-43.31%-22.52%-3.08%-1.88%-31.41%-30.15%27.81%-51.55%9.28%-4.05%6.31%-15.81%-5.06%-25.28%-1.8%3.26%-24.31%1.88%-1.63%7.14%
Operating CF Growth %-831.73%55.27%-521.41%-82.46%563.86%155.83%-33.45%64.09%-317.25%69.94%28.43%-178.41%-271.66%-95.81%93.64%-17.7%-227.56%129.42%-404.53%426.78%-173.88%159.02%-217.88%79.03%-1588.05%-122.35%116.97%-1841.52%151.51%-122.13%-
Net Income2.14M-7.13M-3.91M33.16M14.56M9.45M-2.03M-2.8M-5.24M528K-5.65M-6.79M-6.65M422K-3.42M-3.39M-3.37M-481K-29.97M10.57M2.43M810K-4.87M-3.96M-4.54M-5.27M-141K-2.6M-2.33M2.4M3.3M
Depreciation & Amortization2.58M2.8M3.39M1.36M450K307K310K384K431K417K271K203K135K141K322K491K573K690K644K474K323K340K323K384K582K662K651K703K453K479K600K
Stock-Based Compensation6.97M6.76M5.16M2.52M03.01M0910K905K996K999K1.02M997K829K601K709K01.73M1.27M000000000000
Deferred Taxes-4.31M-4.71M-421K-20.77M000000000000004.94M-4.94M000001.61M00-456K-102K-1M
Other Non-Cash Items964K764K584K-130K2.28M-1.7M-1.3M45K-3K-58K201K166K1K-26K0-973K963K360K13.94M990K758K74K226K160K380K15K1.64M33K-140K142K100K
Working Capital Changes-14.43M-1.79M-12.2M-14.38M-7.28M-9.56M316K-561K-1.74M-3.23M-313K-881K3.26M-1.97M2.19M-1.71M-2.31M945K-1.86M-3.47M-4.62M277K1.78M2.62M-233K2.75M-1.14M-4.09M2.81M-3.59M5M
Change in Receivables-15.13M-3.31M-3.04M6.79M-3.79M-7.83M-1.37M1.16M-2.04M1.26M-3.51M887K1.77M-720K-206K-1.28M-501K267K-3.61M-4.45M-2.09M-2.02M1.72M00000000
Change in Inventory-9.24M11K-2.44M-13.73M-9.47M-6.67M-972K1.16M-112K-2.07M430K70K-1.01M-740K702K-1.11M-1.32M837K5.72M-492K-2.45M-37K849K1.28M-64K1.5M1.09M-1.89M2.74M-1.63M-2.9M
Change in Payables9.62M991K-714K-3.89M5.04M1.36M1.88M-1.02M210K-1.09M1.69M564K-850K707K243K570K-353K-446K-1.99M000000000000
Cash from Investing-2.52M-3.87M-16.07M17.25M-18.66M-416K-227K-163K-173K-572K-477K-919K-118K-289K-127K1.33M-15K-69K-1.11M1.93M-2.49M2.48M3.26M-3.91M4.62M-2.96M1.04M8.55M-1.41M-16.75M-200K
Capital Expenditures-724K-2.07M-4.99M-749K-1.36M-416K-227K-163K-173K-572K-477K-919K-118K-339K-127K-45K-15K-69K-1.11M-1.06M-1.1M-149K-296K-159K-261K-954K-122K-1.36M-755K-315K-600K
CapEx % of Revenue0.99%4.13%8.47%1.13%2.1%0.82%1.37%0.73%0.82%1.94%2.52%6.34%1.18%1.72%0.77%0.29%0.11%0.59%5.2%2.7%4.03%0.63%1.84%1.01%1.73%7.59%0.39%5.54%4.16%0.77%1.43%
Acquisitions-1.8M-1.8M-11.07M000000000050K00000000000000000
Investments-------------------------------
Other Investing00000000000000000000-5K-4K-5K416K-87K-19K-787K-274K9K-213K400K
Cash from Financing93.07M97.21M625K139K7.32M25.76M1.96M2.17M-5.55M925K21.84M2.51M6.41M391K1.06M1.58M343K176K503K2.34M766K514K247K960K-23K338K301K356K-356K22.86M-2.1M
Debt Issued (Net)00000-1.4M1.4M1.68M-6.11M001.99M2.98M-324K-307K1.41M0000000000-419K-170K306K-4.55M-2.13M
Equity Issued (Net)93.25M97.23M625K139K7.32M27.16M560K493K559K925K21.84M512K3.43M715K1.37M168K343K176K503K2.34M766K514K247K960K-23K254K804K526K-662K27.41M-9K
Dividends Paid0000000000000000000000000000000
Share Repurchases-6.51M-2.36M-784K-1.6M-2.06M-429K-20K-10K0000000000000000-182K-141K-468K-136K-1.15M-1K-9K
Other Financing-181K-20K0000000000000000000000084K-84K0000
Net Change in Cash86.39M90.03M-23.93M19.11M-1.43M26.9M-851K5K-11.42M-955K16.86M-4.59M3.72M-515K251K-1.95M-3.75M3.41M-11.29M9.08M-2.84M9.4M4.95M-3.72M877K-2.91M2.07M2.99M-1.41M5.57M-2.1M
Free Cash Flow-6.81M-5.38M-12.39M1.01M8.65M1.09M-2.93M-2.19M-5.81M-1.92M-4.97M-7.2M-2.37M-946K-437K-4.92M-4.16M3.18M-12.15M2.57M-2.21M1.35M-2.84M-959K-4.08M-1.18M889K-7.31M-413K-979K2.4M
FCF Margin %-9.33%-10.75%-21.01%1.52%13.31%2.15%-17.64%-9.81%-27.59%-6.51%-26.31%-49.65%-23.7%-4.81%-2.65%-31.7%-30.26%27.22%-56.75%6.58%-8.09%5.68%-17.66%-6.07%-27.01%-9.39%2.86%-29.84%-2.28%-2.4%5.71%
FCF Growth %58.11%56.62%-1330.59%-88.36%692.03%137.3%-33.88%62.36%-202.13%61.32%30.94%-203.29%-150.95%-116.48%91.12%-18.35%-230.81%126.16%-573.09%216.09%-263.61%147.62%-196.04%76.47%-245.42%-232.73%112.16%-1670.7%57.81%-140.79%-
FCF per Share-0.20-0.18-0.420.030.300.04-0.12-0.10-0.26-0.08-0.31-0.55-0.20-0.08-0.05-0.55-0.470.37-1.440.30-0.270.18-0.38-0.13-0.57-0.170.12-1.07-0.06-0.140.53
FCF Conversion (FCF/Net Income)-3.18x0.46x1.89x0.05x0.69x0.16x1.33x0.72x1.08x-2.56x0.80x0.93x0.34x-1.44x0.09x1.44x1.23x-6.75x0.37x0.34x-0.46x1.85x0.52x0.20x0.84x0.04x-7.17x2.29x-0.15x-0.28x0.91x
Interest Paid000015K12K6K000000000000000000000000
Taxes Paid60K60K100K90K21K4K15K000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile order-driven cash burn

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Earnings Repeatedly Diverge From Operating Cash

According to the reported quarterly cash flow statements, AEHR's operating cash flow was negative in five of the ten quarters shown, including -$3.1M in 2027Q1 against positive net income of $7.2M, a gap that warrants further investigation.

The 2027Q1 result, where net income of $7.2M coincided with operating cash outflow of $3.1M, suggests that reported profit is not converting into cash in the period and that working capital absorbed roughly $12.7M. The OCF/NI ratio swinging between 0.05 and 5.71 indicates that quarterly net income is a poor proxy for cash generation at this company. Investors should monitor whether the 2027Q1 working capital build reverses in subsequent quarters or reflects a structural shift in receivables and inventory.

Free Cash Flow Turns Positive Only Briefly

Based on reported figures, AEHR's free cash flow margin ranged from -46.0% to +16.6% across the ten quarters, with only 2024Q4, 2025Q1 and 2026Q4 producing positive FCF, pointing to an unstable cash generation profile.

The FCF trajectory is dominated by volatility rather than a sustained trend, and the single strongly positive quarter in 2025Q1 coincided with a $10.6M acquisition outflow that is excluded from FCF but still consumed cash. The most recent quarter's negative FCF of -$3.1M, after a positive 2026Q4, appears to reflect working capital timing rather than a clear operating improvement. The data suggests cash generation depends heavily on the timing of order receipts and collections.

Working Capital Swings Drive Cash Outcomes

As reflected in the cash flow statements, working capital changes ranged from -$12.7M in 2027Q1 to +$0.1M in 2025Q1, indicating that receivables, inventory and payables movements are the primary swing factor in AEHR's quarterly cash results.

The magnitude of the 2027Q1 working capital outflow, roughly four times the 2025Q4 outflow, suggests a sharp build in receivables or inventory tied to the revenue rebound from $9.9M to $33.0M. Rapid revenue growth consuming cash is consistent with a company shipping large order volumes before collecting payment. Investors should watch collection cycles closely, as the reported figures do not isolate receivables from inventory.

Capital Intensity Remains Minimal

According to reported figures, AEHR's capital expenditure stayed between 0.1% and 20.0% of revenue, with most quarters under 3%, indicating a light physical asset base relative to its operating scale.

The spike to 20.0% of revenue in 2025Q4 reflects a period of low revenue combined with $2.8M of capex, so the ratio overstates structural intensity. Depreciation and amortization of roughly $0.1M to $1.0M per quarter sits well below the largest capex outlays, which may indicate some capacity or development investment not yet reflected in depreciation. The data does not separate maintenance from growth capex, so the true reinvestment requirement cannot be determined from the supplied figures.

Cumulative Cash Lags Reported Earnings

Based on the ten-quarter reported figures, cumulative net income is approximately $25.9M while cumulative operating cash flow is roughly -$6.9M, a divergence that suggests reported profitability has not translated into cash for AEHR over this window.

The cumulative gap is driven heavily by the $23.9M net income in 2024Q4, which the prior income statement analysis links to a large non-operating or tax-related item rather than core operations. Stripping that quarter out, the underlying net income base is closer to losses, which would be consistent with the negative operating cash flow pattern. This suggests earnings quality is weak and that headline profits should not be relied upon as an indicator of cash generation.

Cash Burn May Reflect Timing Not Structure

Based on the reported quarterly figures, a bull case would argue that AEHR's recent operating cash outflows are largely timing-driven working capital builds around a revenue rebound, rather than evidence of a structurally cash-consumptive business model.

If the 2027Q1 receivables and inventory build reverses as revenue is collected, the reported OCF deficit could narrow sharply and the apparent weakness in conversion would prove transitory. The positive operating cash flow in 2024Q4 and 2025Q1, alongside the 2026Q4 FCF turn, indicates the business has generated cash in past quarters. Investors should monitor subsequent collection cycles, since the supplied data cannot confirm whether the working capital build is temporary.

AEHR — Frequently Asked Questions

Quick answers to the most common questions about buying AEHR stock.

How much cash does Aehr Test Systems (AEHR) generate from operations?

Aehr Test Systems (AEHR) generated $-3.3M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Aehr Test Systems's free cash flow?

Aehr Test Systems (AEHR) reported negative free cash flow of $5.4M in 2026, indicating capital requirements exceeded cash from operations.

What is Aehr Test Systems's capital expenditure (CapEx)?

Aehr Test Systems (AEHR) spent $2.1M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Aehr Test Systems distribute cash to shareholders?

In 2026, Aehr Test Systems (AEHR) spent $2.4M on share repurchases. This shows the company's commitment to returning capital to its equity investors.